ARCHIVES

MGI Pharma, MethylGene Begin Phase II Trial Of MG98.

This article is from The Cancer Letter archive.

Vol. 27 No. 35 | September 28, 2001

Download PDF Visit The Full Archive

Related Articles

In Brief: Kea, Montes Leave DCPC; Smart Heads Early Detection Branch; Costlow Special Assistant

October 3, 1986

NCI Director Broder’s Year In Review: Avoid Politics, Stay Focused On Science

October 28, 1994

Nurse Participation In International Congress Increases

September 19, 1986

Columbia To Host U.S.- China Conference

February 15, 1980

HHS Debars Straus, Who Concedes “Serious Deficiencies” In Trials

May 21, 1982

Cancer Cases To Double By 2050, Annual Report Says

May 31, 2002